Blue Trust’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Blue Trust's TGTX Position: Q3 2026 in Review
Blue Trust reduced its TG Therapeutics (TGTX) stake by 98% in Q3 2026, selling an estimated $10.3K and leaving 3 shares worth $167. The position accounts for ﹤0.01% of the portfolio, ranked #2392.
Blue Trust first reported a position in TGTX in Q3 2022 and has held it in 14 quarters since. The position peaked at $83.7K in Q1 2025. 370 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Blue Trust held 3 shares of TG Therapeutics worth $167 as of Q3 2026.
- Blue Trust sold 191 TG Therapeutics shares in Q3 2026, an estimated $10.3K.
- TG Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2392 holding.
- Blue Trust first reported a position in TG Therapeutics in Q3 2022 and has held it in 14 quarters since.
- Blue Trust's TG Therapeutics position peaked at $83.7K in Q1 2025.
- 370 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.